Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ulcerative colitis
ulcerative colitis
Lilly's experimental colitis drug posts positive Phase 2 data
Biopharma Dive
Wed, 06/6/18 - 03:04 pm
Eli Lilly
mirikizumab
ulcerative colitis
monoclonal antibodies
Pfizer's Xeljanz jumps into ulcerative colitis fray with best-case FDA approval
Fierce Pharma
Thu, 05/31/18 - 10:58 am
Pfizer
Xeljanz
FDA
ulcerative colitis
Gilead, Galapagos hit goal in psoriatic arthritis phase 2
Fierce Biotech
Thu, 05/31/18 - 09:33 am
Gilead Sciences
Galapagos
filgotinib
psoriatic arthritis
clinical trials
ulcerative colitis
Teva launches generic version of Shire's top-selling internal medicine
Biopharma Dive
Thu, 03/29/18 - 09:54 am
Teva Pharmaceutical
generics
Shire
Lialda
ulcerative colitis
Protagonist cans ulcerative colitis trial after flunking interim review
Fierce Biotech
Tue, 03/27/18 - 10:59 am
Protagonist Therapeutics. clinical trials
ulcerative colitis
PTG-100
Arena Pharmaceuticals Takes Aim at Celgene
Motley Fool
Fri, 03/23/18 - 09:35 pm
Arena Pharmaceuticals
Celgene
etrasimod
ozanimod
ulcerative colitis
Here's Why Arena Pharmaceuticals, Inc. Surged Again on Wednesday
Motley Fool
Wed, 03/21/18 - 11:40 pm
Arena Pharmaceuticals
etrasimod
ulcerative colitis
Arena Pharmaceuticals Takes a Big Step Forward
Motley Fool
Tue, 03/20/18 - 09:43 am
Arena Pharmaceutical
etrasimod
ulcerative colitis
clinical trials
Protalix’ oral anti-TNF drug hits the mark in phase 2 ulcerative colitis trial
Fierce Biotech
Tue, 03/13/18 - 11:51 am
Protalix
anti-TNF
clinical trials
ulcerative colitis
OPRX-106
Pfizer Gets FDA Panel Backing for New Indication for Xeljanz
Yahoo/Zacks.com
Fri, 03/9/18 - 10:50 am
Pfizer
FDA
advisory panels
Xeljanz
ulcerative colitis
J&J strikes potential $1B JAK inhibitor deal with Theravance
Biopharma Dive
Wed, 02/7/18 - 10:06 am
JNJ
JAK inhibitors
Theravance
TD-1473
drug development
Crohn's Disease
ulcerative colitis
With help from J&J, upstart Provention lands rights to two mid-stage IBD drugs and shoots for PhII
Endpoints
Thu, 09/21/17 - 08:49 am
JNJ
Provention Bio
IBD
inflammatory bowel disease
PRV-6527
Crohn's Disease
PRV-300
ulcerative colitis
Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016
Yahoo
Sat, 10/15/16 - 12:18 pm
Pfizer
Xeljanz
ulcerative colitis
AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
Endpoints
Mon, 10/3/16 - 10:09 am
AstraZeneca
Amgen
Allergan
MEDI2070
ulcerative colitis
Crohn's Disease
Gilead Sciences: Another Blow to R&D Strategy
Barron's
Fri, 09/23/16 - 10:06 pm
Gilead Sciences
R&D
ulcerative colitis
GS-5745
Gilead scraps a PhII/III study early as drug flops against ulcerative colitis
Endpoints
Wed, 09/21/16 - 10:53 pm
Gilead Sciences
ulcerative colitis
clinical trials
GS-5745
Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ® (Tofacitinib Citrate) in Ulcerative Colitis
Yahoo
Fri, 07/29/16 - 11:30 am
Pfizer
Xeljanz
clinical trials
ulcerative colitis
Shire prevails in Lialda patent case against Allergan
BioPharma Dive
Tue, 03/29/16 - 11:18 am
Shire
Lialda
Allergan
patents
Watson
ulcerative colitis
Arena Investors Hope Celgene Trial A Harbinger For Future Returns
Seeking Alpha
Sat, 03/19/16 - 01:52 pm
Arena Pharmaceuticals
Celgene
ozanimod
APD334
ulcerative colitis
Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Oral Tofacitinib in Adults with Moderate-to-Severe Ulcerative Colitis
Yahoo
Mon, 09/21/15 - 10:48 am
Pfizer
tofacitinib
ulcerative colitis
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »